ASCO has announced the three recipients of its CancerLinQ Discovery® Research Support Grant. The awardees will undertake research projects using data from CancerLinQ Discovery®, an offering of ASCO’s CancerLinQ® initiative that provides deidentified data from patients to academic researchers, government agencies, and others in the oncology community to generate practical knowledge that will improve cancer care.
CancerLinQ® collects and analyzes real-world data from patients at practices nationwide, drawing from electronic health records. The CancerLinQ Discovery® deidentified data sets are derived from the vast pool of data contributed by participating practices. The research projects funded by this grant are consistent with ASCO’s mission to conquer cancer through research, education, and promotion of the highest quality patient care and are being addressed using CancerLinQ Discovery® data. These findings will be published in medical journals.
The recipients of the CancerLinQ Discovery® Research Support Grant and their projects are as follows:
The grants are being funded by the Mission Endowment of Conquer Cancer®, The ASCO Foundation. Each 1-year grant covers the cost of a CancerLinQ Discovery® data set and a kickoff meeting at ASCO headquarters, and also contributes to personnel and/or research expenses.
Conquer Cancer Mission Endowment provides a long-term base of support to advance the Foundation’s critical mission to improve the care and treatment of people living with cancer. The endowment is the cornerstone of its efforts to extend the reach and impact of its work and allows Conquer Cancer to continue to support the best opportunities for scientific research, professional development, and patient education well into the future. Mission Endowment provides a stable flow of funds to increase grant funding, sustain existing programs, develop new initiatives, and reach new audiences around the world.
CancerLinQ® and CancerLinQ Discovery® are projects of CancerLinQ LLC. For more information about either initiative, please go to www.CancerLinQ.org. ■
© 2019. American Society of Clinical Oncology. All rights reserved.